Research Peptides Glossary

This glossary brings together the terms that appear most often in RUO catalogs, certificates of analysis, and technical literature on research peptides. Here you will find clear definitions of common molecules, quality concepts such as HPLC and LC-MS, and basic notions of classification, stability, and analytical documentation.

At 24Peptides we prioritize batch traceability, independent third-party analysis, and documentary transparency. The information on this page is educational and research-oriented. RUO materials are for research use only, not for human use and only for those over 18 years of age.

What are research peptides

A peptide is a chain of amino acids linked by peptide bonds. In research, these molecules are used as tools to study cellular signaling, receptor interaction, inflammation, metabolism, epithelial barrier, and other biological processes. The sequence is typically described from the N-terminus to the C-terminus, and small changes in that sequence can substantially alter the observed activity.

The difference between a peptide and a protein does not depend only on the number of amino acids, but in practical terms peptides are usually shorter and easier to characterize. In this context, a good glossary should not be limited to the molecule’s name. It should also explain how to interpret purity, identity, salt or counterion, lyophilization, reconstitution, and certificate of analysis, because those data directly influence the reading of an RUO material.

How peptides are classified

By biological function

A useful way to classify them is by the biological pathway they study. This includes, for example, incretins and GLP-1-related agonists, GH-axis secretagogues, immunomodulatory peptides, neuroactive peptides, and peptides used in dermal or cosmetic research. This classification helps explain why very different molecules appear together in the same catalog.

By chemical structure

They can also be classified by their architecture. There are linear and cyclic peptides, sequences with disulfide bridges, peptide-metal complexes such as GHK-Cu, and analogs modified to change stability, affinity, or half-life. Two similar names do not guarantee equivalence if the sequence, chain length, or chemical modification differ.

By experimental context

Another relevant classification separates endogenous peptides, synthetic analogs, fragments of natural sequences, and related compounds that are sometimes grouped by search affinity even if they are not peptides in the strict sense. Therefore, when asking which peptides are most used, it is often more useful to talk about research families than about a single closed list.

Quality and documentation: the terms that matter most

If you only review one part of the glossary before comparing RUO materials, it should be this one. Understanding a product name is useful, but understanding its analytical documentation is essential.

Term	What it indicates	What to check
COA	Batch analytical document	Batch number, date, laboratory, methods and results
HPLC	Chromatographic purity	Whether purity is expressed by peak area and what its limitations are
LC-MS	Identity and molecular mass	Expected mass, exact variant and consistency with the sequence
RUO	Research use only	Scope of use, labeling and material traceability
Endotoxins and bioburden	Contamination controls	Whether complementary tests exist appropriate to the experimental context

COA and batch traceability

A COA, or Certificate of Analysis, must be batch-specific. A generic product sheet is not enough. A useful document identifies the batch number, analysis date, the laboratory or assay system used, and the results obtained for purity, identity, and other relevant controls. When the same trade name appears in different batches, the COA is what allows you to verify whether the material really corresponds to the same specification.

In a serious research setting, traceability matters as much as the numeric value. Without traceability, reproducibility is compromised. That is why, at 24Peptides, we prioritize batch-accessible documentation and external verification as part of the transparency standard.

HPLC and peak-area purity

HPLC stands for high-performance liquid chromatography, and it is one of the most used methods to estimate purity. In RUO peptides, the purity figure is usually expressed as peak-area purity: a chromatographic estimate of how much the main peak represents versus detectable impurities under that specific method.

A common mistake is to interpret 99% HPLC as if it meant 99% actual content by weight. Not necessarily. The salt form, residual moisture, certain counterions, and other components can influence the material’s total mass without changing the chromatographic readout in the same way. Therefore, HPLC purity and correct identity are necessary, but they do not automatically equate to the same analytical conclusion.

LC-MS, molecular mass, and salt form

LC-MS combines chromatographic separation with mass spectrometry and is used to confirm identity and molecular mass. In a research peptides glossary, this term is key because it helps distinguish similar molecules, sequence variants, and analogs with differences that are not always visible in a simple commercial description.

It is also advisable to pay attention to the salt form and counterion, such as TFA or acetate, because they can affect interpretation of the material. Likewise, parameters such as molecular mass in Da or kDa and, in some cases, the isoelectric point provide context on solubility, behavior, and batch-to-batch consistency.

RUO, third-party testing, and quality standards

RUO means Research Use Only, i.e., for research use only. It is a use-destination labeling, not a quality test by itself. Nor is it synonymous with GMP processes. In practice, what matters is that the supplier supports that labeling with traceability, clear analytical controls, and verifiable documentation.

Third-party tests reduce the risk of relying only on internal statements. At 24Peptides, quality is supported by independent batch-by-batch analyses and a policy of documentary transparency. For many R&D teams, that offers a more useful criterion than a simple purity promise without complete data behind it.

Handling, reconstitution, and stability

Lyophilization and reconstitution

Lyophilized means the material has been dehydrated by freezing and vacuum to improve stability during storage. Reconstitution means dissolving that material again in a medium appropriate to the experimental context. Although both terms are basic, they do not describe a single universal practice: the sequence, target concentration, salt form, and the laboratory’s protocol can change the appropriate approach.

Solvents, aliquots, and cold chain

In RUO literature, bacteriostatic water, sterile water, and acidified or buffered media appear frequently. They are not equivalent to each other, and their choice depends on chemical compatibility, stability, and experimental design. Terms such as aliquots, cold chain, and freeze-thaw cycles are also common. Fractionating the material and reducing repeated exposure to temperature, moisture, and light is often important to preserve analytical consistency.

Degradation and stability factors

Among the most cited degradation routes are oxidation, hydrolysis, deamidation, and aggregation. In sensitive peptides, residual moisture, pH, light exposure, and repeated thermal changes can alter the batch profile over time. Therefore, stability depends not only on the peptide’s name but also on how it was formulated, how it was stored, and which analytical controls accompany the batch.

Common pharmacological and analytical concepts

Agonist, antagonist, receptor, and GPCR

Many research peptides are described as agonists or antagonists. An agonist activates a receptor; an antagonist blocks or reduces that activation. In RUO catalogs it is common to find references to GPCRs, a large family of receptors involved in hormonal and neurochemical signaling. Understanding this terminology helps explain why two peptides can belong to the same functional family without sharing the same sequence.

EC50, IC50, half-life, and bioavailability

EC50 and IC50 are common assay metrics and describe the concentration associated with a given response or inhibition. They are not equivalent to absolute potency and cannot be compared without experimental context. Half-life and bioavailability are also cited frequently, but should be read carefully: a short plasma half-life does not necessarily imply an identically short biological duration.

In vitro, in vivo, and experimental context

In vitro and in vivo are not interchangeable settings. A result in cell culture does not automatically translate to a more complex biological system. In a useful glossary, these terms should remind you that a peptide’s value depends as much on its identity and purity as on the experimental model, the assay, and the quality of the documentation that accompanies it.

Essential glossary A-Z

The following entries summarize peptides and related compounds that recur in searches, catalogs, and RUO literature. When a term does not correspond to a peptide in the strict sense, this is stated explicitly.

A-C

Argirelina

Argirelina, or Acetyl Hexapeptide-8, is a peptide used mainly in dermocosmetic research for its relation to superficial neuromuscular signaling. It should not be confused with endocrine or immunological peptides.

BPC-157

BPC-157 is a synthetic fragment frequently cited in barrier and tissue repair models. Given its high commercial popularity, it is advisable to review sequence, identity, and batch COA with particular care.

CJC-1295

CJC-1295 is a GHRH analog. It may appear in versions with DAC and without DAC, which are not equivalent in pharmacokinetics or in designation. The exact variant should be clear in the analytical documentation.

D-G

GHK-Cu

GHK-Cu is a complex of the tripeptide GHK with copper. It is studied in cutaneous and extracellular matrix contexts, and its complexed form is not exactly the same as the free tripeptide.

GLP-1

GLP-1 is an endogenous incretin involved in metabolic signaling. In RUO catalogs it also functions as a class reference for GLP-1 receptor agonists, so the term does not always point to the same molecule.

GHRP-6

GHRP-6 belongs to the family of growth hormone secretagogues and is related to the ghrelin receptor. It is a different class from GHRH analogs, even though they are often mentioned together.

H-M

IGF-1

IGF-1 is a peptide growth factor associated with the GH-IGF axis. Variants such as LR3 or DES are not interchangeable and should be verified by exact name, sequence, and molecular mass.

Ipamorelina

Ipamorelina is a GH secretagogue described for its relative selectivity within the group of ghrelin receptor agonists. In research it is often compared with GHRP-2, GHRP-6, and other GH-axis compounds.

KPV

KPV is a short tripeptide derived from a sequence related to alpha-MSH. It usually appears in inflammatory and barrier signaling models, where purity, solubility, and salt form are especially relevant.

LL-37

LL-37 is a human cathelicidin of innate immunity. In research it is linked to inflammation, epithelial barrier, and antimicrobial response. It can also appear under the broader category of cathelicidins.

Melanotan II

Melanotan II is a synthetic analog of the melanocortin system. To interpret it correctly, it is advisable to distinguish the specific molecule, its receptor profile, and other related compounds such as PT-141.

MOTS-c

MOTS-c is a mitochondria-derived peptide that appears frequently in metabolic and cellular stress research. Interest usually centers on energy signaling rather than classical endocrinology.

N-S

NAD+

NAD+ is not a peptide, but it is often included in catalogs of research compounds related to metabolism and redox. It should be clearly distinguished from peptides even if it shares experimental context.

PT-141

PT-141, or bremelanotida, is a melanocortin receptor agonist derived from lines of research close to Melanotan. It does not belong to the GLP-1 family or to GH secretagogues.

Selank

Selank is a synthetic peptide of neuroactive interest cited in studies of behavioral modulation and central signaling. As with other short peptides, the exact sequence and batch identity are essential.

Semax

Semax is a synthetic peptide derived from fragments related to ACTH and is studied in neuroactive contexts. It should not be treated as synonymous with Selank, even though both appear together in many catalogs.

Semaglutida

Semaglutida is a GLP-1 peptide analog designed to prolong its residence and activity. In a glossary it is appropriate to place it as a GLP-1 receptor agonist, not as equivalent to endogenous GLP-1.

Sermorelina

Sermorelina is a short GHRH analog used as a reference within GH-axis research. It is often compared with CJC-1295 and tesamorelina, although each molecule has a different structure.

T-Z

TB-500 / Timosina beta-4

TB-500 and timosina beta-4 are often mixed in commercial language, but they do not always name exactly the same sequence or presentation. That is why it is key to review stated sequence, molecular mass, and COA.

Timosina alfa-1

Timosina alfa-1 is a thymic peptide studied in immunology and inflammation. It must be distinguished from timosina beta-4 and similarly named products, because its sequence and biological context are not the same.

Tirzepatida

Tirzepatida is a peptide analog with dual action on GIP and GLP-1 in metabolic research literature. Its class is not identical to that of simple GLP-1 receptor agonists.

VIP

VIP, or vasoactive intestinal peptide, is a neuropeptide involved in vascular, gastrointestinal, and immunological signaling. In research it appears both for its receptor activity and for its role in barriers and mucosae.

Frequently asked questions about research peptides

What are research peptides?

They are amino acid sequences used as experimental tools to study signaling pathways, receptors, metabolism, inflammation, and other biological functions. In an RUO context, what matters is not only the peptide’s name, but also its identity, purity, and documentary traceability.

What is the difference between a peptide and a protein?

In practical terms, peptides are usually shorter chains and simpler to characterize than proteins. The boundary is not absolute, but in research catalogs this distinction serves to separate smaller molecules from more complex protein structures.

How are peptides classified?

They can be classified by biological function, by chemical structure, or by experimental context. Thus, for example, one distinguishes incretins and GLP-1 agonists, GH-axis secretagogues, immunological peptides, neuroactives, metal complexes, and synthetic analogs.

Which peptides are most used?

It depends on the research area. Among the most searched are GLP-1-related agonists such as semaglutida, dual analogs such as tirzepatida, GH-axis secretagogues such as ipamorelina or CJC-1295, and peptides frequently cited in immunology, neuroscience, or barrier research such as LL-37, Selank, Semax, and thymosins.

What does RUO mean and how does it differ from GMP?

RUO means research use only. It indicates the intended use of the material, not an automatic quality certification. GMP refers to a specific manufacturing and control framework. For RUO materials, the key is to have traceability, a clear COA, and consistent analytical tests.

Does 99% HPLC purity mean 99% actual content?

Not necessarily. HPLC purity is usually expressed by peak area and describes chromatographic homogeneity under a specific method. Actual content by weight can be influenced by moisture, counterions, salts, or other factors that are not interpreted identically in that value.

What should a reliable COA include?

At a minimum, a useful COA should be batch-specific and include batch number, date, analysis method, purity, identity, and data sufficient to interpret the result. Depending on the material and the lab’s intended use, endotoxins, bioburden, or heavy metals may also be relevant.

For 24Peptides, a useful glossary does not end at the definition. Each term should be linkable to verifiable data. That is why we prioritize batch-level transparency, accessible analytical documentation, and research quality backed by independent third-party testing.